5am Opportunities I, L.P. (CIK 0001753000)

Latest company ownership

RLYB - Rallybio Corp
Role: 10% Owner
Shares held
2,478,969
Last filed at
Jun 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
1,899,157
Last filed at
Oct 7, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
VOR - Vor Biopharma Inc.
Role: 10% Owner
Shares held
1,766,634
Last filed at
Nov 18, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
1,093,313
Last filed at
Nov 18, 2025
Confidence Score
20.9
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
635,341
Last filed at
Feb 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
410,268
Last filed at
Oct 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
384,496
Last filed at
Nov 13, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
CABA - Cabaletta Bio, Inc.
Role: 10% Owner
Shares held
333,144
Last filed at
Nov 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 14, 2025 Nov 18, 2025 Entrada Therapeutics, Inc. 10% Owner Sell 17.5 -200,000 -4.70% ✗ $1.8M
Jul 9, 2025 Jul 11, 2025 Entrada Therapeutics, Inc. 10% Owner Sell 32.5 -27,000 -0.63% ✗ $202.6K
Jun 27, 2025 Jul 1, 2025 Entrada Therapeutics, Inc. 10% Owner Sell 20.0 -125,000 -2.84% ✗ $866.6K
Feb 14, 2024 Feb 16, 2024 Enliven Therapeutics, Inc. 10% Owner Sell 15.0 -825,000 -17.70% ✗ $12.3M
Jan 31, 2024 Feb 2, 2024 Enliven Therapeutics, Inc. 10% Owner Sell 16.3 -500,000 -9.69% ✗ $7.5M
Sep 26, 2023 Sep 28, 2023 Enliven Therapeutics, Inc. 10% Owner Sell 17.5 -197,500 -3.69% ✗ $3M
Aug 24, 2023 Aug 28, 2023 Enliven Therapeutics, Inc. 10% Owner Sell 16.3 -440,000 -7.59% ✗ $7M
Oct 6, 2022 Oct 11, 2022 scPharmaceuticals Inc. 10% Owner Sell 17.5 -600,000 -17.99% ✗ $2.5M
Sep 6, 2022 Sep 8, 2022 scPharmaceuticals Inc. 10% Owner Sell 17.5 -226,622 -6.36% ✗ $1.1M
Jun 3, 2022 Jun 7, 2022 Rallybio Corp 10% Owner Sell 17.5 -150,000 -3.87% ✗ $1.9M
May 23, 2022 May 25, 2022 Rallybio Corp 10% Owner Sell 17.5 -100,000 -2.51% ✗ $1.3M
Apr 11, 2022 Apr 13, 2022 scPharmaceuticals Inc. 10% Owner Sell 17.5 -270,000 -7.05% ✗ $1.4M
Feb 8, 2022 Feb 10, 2022 Rallybio Corp 10% Owner Sell 17.5 -210,000 -5.01% ✗ $2.7M
Nov 16, 2021 Nov 18, 2021 Vor Biopharma Inc. 10% Owner Sell 16.3 -330,706 -4.94% ✗ $5.1M
Nov 2, 2021 Nov 4, 2021 Entrada Therapeutics, Inc. 10% Owner Buy 100.0 +250,000 28.33% ✗ $5M
Nov 1, 2021 Nov 3, 2021 Cabaletta Bio, Inc. 10% Owner Sell 17.5 -295,000 -12.50% ✗ $3.8M
Sep 7, 2021 Sep 9, 2021 Cabaletta Bio, Inc. 10% Owner Sell 16.3 -625,000 -23.90% ✗ $6.1M
Aug 2, 2021 Aug 4, 2021 Rallybio Corp 10% Owner Buy 100.0 +615,384 17.21% ✗ $8M
Feb 9, 2021 Feb 9, 2021 Vor Biopharma Inc. 10% Owner Buy 96.3 +555,555 9.05% ✗ $10M
Jan 8, 2021 Jan 12, 2021 Cabaletta Bio, Inc. 10% Owner Sell 16.3 -387,000 -6.01% ✗ $5M
Dec 10, 2020 Dec 14, 2020 Cabaletta Bio, Inc. 10% Owner Sell 17.5 -298,000 -8.12% ✗ $4.4M
Nov 11, 2020 Nov 13, 2020 IDEAYA Biosciences, Inc. 10% Owner Sell 15.0 -800,000 -23.10% ✗ $10.9M
Oct 5, 2020 Oct 7, 2020 Aprea Therapeutics, Inc. Other Sell 17.5 -175,000 -55.82% ✗ $4.4M
Jun 16, 2020 Jun 18, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 17.5 -140,000 -5.95% ✗ $4.7M
Jun 11, 2020 Jun 15, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 16.3 -245,000 -10.82% ✗ $7M
May 19, 2020 May 21, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 16.3 -255,000 -10.12% ✗ $9M
Oct 29, 2019 Oct 31, 2019 Cabaletta Bio, Inc. 10% Owner Buy 100.0 +454,545 100.00% ✗ $5M
Oct 7, 2019 Oct 9, 2019 Aprea Therapeutics, Inc. 10% Owner Buy 100.0 +333,333 100.00% ✗ $5M